Abstract
The creatine transporter (CrT) maintains brain creatine (Cr) levels, but the effects of its deficiency on energetics adaptation under stress remain unclear. There are also no effective treatments for CrT deficiency, the second most common cause of X-linked intellectual disabilities. Herein, we examined the consequences of CrT deficiency in brain energetics and stress-adaptation responses plus the effects of intranasal Cr supplementation. We found that CrT-deficient (CrT–/y) mice harbored dendritic spine and synaptic dysgenesis. Nurtured newborn CrT–/y mice maintained baseline brain ATP levels, with a trend toward signaling imbalance between the p-AMPK/autophagy and mTOR pathways. Starvation elevated the signaling imbalance and reduced brain ATP levels in P3 CrT–/y mice. Similarly, CrT–/y neurons and P10 CrT–/y mice showed an imbalance between autophagy and mTOR signaling pathways and greater susceptibility to cerebral hypoxia-ischemia and ischemic insults. Notably, intranasal administration of Cr after cerebral ischemia increased the brain Cr/N-acetylaspartate ratio, partially averted the signaling imbalance, and reduced infarct size more potently than intraperitoneal Cr injection. These findings suggest important functions for CrT and Cr in preserving the homeostasis of brain energetics in stress conditions. Moreover, intranasal Cr supplementation may be an effective treatment for congenital CrT deficiency and acute brain injury.
Highlights
Creatine (Cr) and phosphocreatine (PCr) show the highest concentration in tissues that require constant or rapid energy supply, including skeletal muscles, heart, and brain [1, 2]
Reverse transcription quantitative PCR (RT-qPCR) analysis validated the absence of full-length Cr transporter (CrT) (Slc6a8) mRNA in the brain, heart, liver, kidney, and skeletal muscles in 5-month-old CrT–/y mice (Figure 1, B, D, and E; n = 4 for each genotype)
Transgenic CrT-null mice are a valuable tool to address these issues, since the Cr biosynthesis pathway, the X-chromosome location of the CrT gene (Slc6a8), and the consequence of cognitive impairment due to CrT deficiency are conserved between humans and mice [1, 2]
Summary
Creatine (Cr) and phosphocreatine (PCr) show the highest concentration in tissues that require constant or rapid energy supply, including skeletal muscles, heart, and brain [1, 2]. Cr/PCr has energy-shuttling functions in skeletal muscles plus neuroprotective and cognition-enhancing effects in the brain [3,4,5]. The addition of Cr delays the onset of anoxia-induced obliteration of the electrical activity in brain slices [6]. Reductions in Cr/PCr levels and Cr kinase activity have been observed in neurodegenerative diseases [4, 9]. The neuroprotective potential of Cr/PCr is yet to be harnessed for treating acute brain injury, mainly due to a sluggish blood-to-brain transport of Cr that is mediated by the Cr transporter (CrT) [12, 13]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.